Endoscopic colorectal cancer screening: a cost-saving analysis.
about
Calibration methods used in cancer simulation models and suggested reporting guidelinesEstimating the Effect of Targeted Screening Strategies: An Application to Colonoscopy and Colorectal Cancer.Performance value of high risk factors in colorectal cancer screening in ChinaIndividualizing colonoscopy screening by sex and race.Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis.At what costs will screening with CT colonography be competitive? A cost-effectiveness approach.A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials.Hospital costs of colorectal cancer careComparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.Preliminary analysis of the cost-effectiveness of the National Bowel Cancer Screening Program: demonstrating the potential value of comprehensive real world data.Community contextual predictors of endoscopic colorectal cancer screening in the USA: spatial multilevel regression analysis.Eight years of colonoscopic bowel cancer screening in Germany: initial findings and projections.Simulation of colorectal cancer screening: what we do and do not know and does it matter.How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?Protagonist: population based endoscopic screening for colorectal cancer.Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policyAs tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasiaManaged care and the diffusion of endoscopy in fee-for-service Medicare.Screening for colon cancerEarly detection of colon cancer-the kaiser permanente northwest 30-year history: how do we measure success? Is it the test, the number of tests, the stage, or the percentage of screen-detected patients?Screening for colorectal cancer using the fecal occult blood test: an actuarial assessment of the impact of a population-based screening program in Canada.Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidenceThe cost-effectiveness of CT colonography in screening for colorectal neoplasia.Option appraisal of population-based colorectal cancer screening programmes in England.Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.Chapter 10: deciding whether to complement a systematic review of medical tests with decision modeling.Colon Capsule Endoscopy for the Detection of Colorectal Polyps: An Economic Analysis.Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies.Challenges in clinical studies with multiple imaging probes.Cost Effectiveness of Screening Colonoscopy Depends on Adequate Bowel Preparation Rates - A Modeling StudyColorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study designA framework for tailoring clinical guidelines to comorbidity at the point of careHarms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screeningContribution of screening and survival differences to racial disparities in colorectal cancer rates.A cost analysis of colonoscopy using microcosting and time-and-motion techniques.Cancer biomarkers: a systems approach.Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis.Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.Review of economic evidence in the prevention and early detection of colorectal cancer.A cost-effectiveness analysis of folic acid fortification policy in the United States.
P2860
Q28749665-DCA5556E-DEC0-47FA-A87A-AB6CDDF07A0FQ30854346-2E3E6CBE-F4EB-4799-BF36-972BC265DFA6Q33555391-5CD0AE45-0F37-430F-AD5A-A36662A7E3E5Q33588581-7F96A234-7FA4-4EE8-B04A-69C11B61D66CQ33774326-C0C4C010-729B-4FB6-ABEA-414253540883Q33810469-0D1C3334-3E66-4B06-A76C-4E3D77F4C38FQ33860050-31E35942-69FB-450D-985F-7FD2CF8422EFQ33860267-BFEDC46E-D0E4-4ED2-9DD6-AA750FE99A67Q33981053-BED3E35C-D745-4B4E-AEBE-0B1EA13172ADQ34007614-65F5388E-B1F3-47EC-879D-C7D1FFC7DA6FQ34138849-4E1240A4-1029-4420-B967-A249E4C7474AQ34316723-B2C475E2-1E6C-494B-80F1-4BCE3EDFEA98Q34342290-5773AC15-7A1A-40C9-9310-4636987644F5Q35046586-3238274D-43A7-46DA-987F-CC288E994327Q35065312-A56B41C6-DF27-4146-834C-10E96BEACFA0Q35173359-C1C65EA4-75D3-4ED0-ABC1-CE9ECE70DEBFQ35206019-E1823AF6-356D-4B00-8843-6F6E6F20CFC8Q35581435-6F252593-2BDB-434A-9659-653D582A1D5CQ35650647-7DA38201-75F8-4FC3-A3AE-5A73D9C32394Q35703309-6D37DE6B-94E6-48CF-ADF2-73D50EC57B09Q35750550-D239C6CA-7FA9-4122-AC1A-8DCBDDB64F0EQ35768888-DD17E6F0-3670-4650-A30D-E643DAFF0922Q35774623-9B419113-D659-4159-BE6E-3DDB9CCED9D9Q35929500-8A6471B2-8050-42F5-9FA7-C565EBCF9C1FQ35980669-859C7576-DB7D-4EC1-9AFC-DE5C3D9880D9Q35999029-D11933BD-A821-4C42-B47B-F9808255DAD4Q36033510-14B79812-637E-44D0-AB30-57513E29E8D3Q36172692-EEFEBA92-8158-4A45-8A9D-B6425A7F3330Q36177540-9D34FF34-374D-47F3-9D1A-1D439D38F319Q36217888-CAA84BE0-E33B-41DF-B6FC-840FA2BF1CA7Q36273279-CE26DB73-3248-4953-A793-83DD8612EB47Q36285981-228CB600-E04E-4565-AE96-0061A3E4A25AQ36309075-728A9677-2C27-4056-BD06-1DEE889041C5Q36493434-DB81E84D-8A67-4348-97D8-81268A62F585Q36552245-242C60D1-6A5F-4B54-814B-D2D5B87447D1Q36561609-CCD03948-7307-4D33-A3C6-A1455FB62263Q36627490-53826104-0AF2-4650-BE15-4E75295C1E1EQ37318617-AD500830-BC3C-4F57-9E77-A8DD7737F5FDQ37356637-382DD6D9-5759-470B-B23C-E24379192F1AQ37377199-00F13125-90CB-46E8-8BDF-4285B3020F73
P2860
Endoscopic colorectal cancer screening: a cost-saving analysis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Endoscopic colorectal cancer screening: a cost-saving analysis.
@en
Endoscopic colorectal cancer screening: a cost-saving analysis.
@nl
type
label
Endoscopic colorectal cancer screening: a cost-saving analysis.
@en
Endoscopic colorectal cancer screening: a cost-saving analysis.
@nl
prefLabel
Endoscopic colorectal cancer screening: a cost-saving analysis.
@en
Endoscopic colorectal cancer screening: a cost-saving analysis.
@nl
P2093
P356
P1476
Endoscopic colorectal cancer screening: a cost-saving analysis.
@en
P2093
Habbema JD
van Ballegooijen M
van Oortmarssen GJ
P304
P356
10.1093/JNCI/92.7.557
P407
P50
P577
2000-04-01T00:00:00Z